NCT05210790 | PTG-300-11 | DRUG CO

NCT Number: NCT05210790

Protocol ID: PTG-300-11

Sponsor: DRUG CO

Disease Site: Blood Disorders-Other

Disease Category: Blood Disorders-Other

Detail: A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera

Interested in participating in this trial?

Clinical Trial

First Name

Last Name

Phone

Preferred Contact Method:

Preferred Location:

Patient Type:

Current Patient New Patient

Interested in:

Cancer Clinical Trial Blood Disorder Clinical Trial

Disease Site:

Disease Category

The National Clinical Trial (NTC) is assigned by the National Library of Medicine when a new study appears in the clinical trials database.

ex: NCT0526225 | GY026 | NRG

Any unique identifier assigned to the protocol by the sponsor.

ex: NCT0526225 | GY026 | NRG

A sponsor is an individual, institution, company or organization that takes the responsibility to initiate, manage and/or finance the clinical trial.

ex: NCT0526225 | GY026 | NRG